Purple Biotech Ltd. ADS (PPBT)
NCM · ADR · CUSIP 74638P109
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for PPBT and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
74638P109 (prev. 49803V107 )
Market Cap
Micro Cap
IPO
11/20/2015 · $4.12/share
ADR Ratio
1:10
Previous Symbol
KTOV (changed 12/3/2020)
Previous Name
Kitov Pharma Ltd
Business: Purple Biotech Ltd. is a clinical-stage company developmenting first-in-class, effective therapies that harness the power of the tumor microenvironment (TME) to overcome drug resistance and improve treatment outcomes for cancer patients.
Notes: Jan, 04 2019 -- Effected a 20:1 reverse stock split, on Jan 07,2019 the ADR ratio changed from 1:20 to 1:1. __________________ November 2015 -- Each ADS, representing 20 ordinary shares of the Company, and each warrant to purchase one ADS, are offered at a combined price to the public of $4.13. The warrants will have a per ADS exercise price of $4.13, are exercisable immediately, and will have a term of five years.

Company Contact

CEO
Gil Efron
CFO
Lior Fhima
Headquarters
1615 Suter’s Lane NW, Washington, DC 20007
Phone
202-965-2215
Investor Relations
IR@purple-biotech.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »